Rate of exacerbations requiring emergency department treatment or admission · people with asthma
Mepolizumab intravenous (IV) leads to lower rate of exacerbations requiring emergency department treatment or… compared with placebo (high certainty).
1 finding from 1 review
Caesarean section · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation may leads to lower caesarean delivery compared with continued IV oxytocin stimulation (low certainty).
1 finding from 1 review
Caesarean delivery after active phase has begun, using "reached active phase" as the denominator · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation showed no clear difference in caesarean delivery after active phase has begun, using "reached… compared with continued IV oxytocin stimulation (moderate certainty).
1 finding from 1 review
Uterine tachysystole combined with abnormal fetal heart rate · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation probably leads to lower uterine tachysystole combined with abnormal fetal heart rate compared with continued IV oxytocin stimulation (moderate certainty).
1 finding from 1 review
Chorioamnionitis · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
It is very uncertain whether discontinued intravenous (IV) oxytocin stimulation changes chorioamnionitis compared with continued IV oxytocin stimulation (very low certainty).
1 finding from 1 review
Use of analgesia and epidural during labour · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation may leads to higher use of analgesia and epidural during labour compared with continued IV oxytocin stimulation (low certainty).
1 finding from 1 review
Intrapartum cardiotocography (CTG) abnormalities (suspicious/pathological CTGs) · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation probably leads to lower intrapartum cardiotocography (CTG) abnormalities… compared with continued IV oxytocin stimulation (moderate certainty).
1 finding from 1 review
Apgar score less than 7 at 5 minutes · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation may leads to lower apgar score at five minutes below seven compared with continued IV oxytocin stimulation (low certainty).
1 finding from 1 review
Acidotic cord gasses (arterial umbilical pH < 7.10) · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation may leads to higher acidotic cord gasses (arterial umbilical pH < 7.10) compared with continued IV oxytocin stimulation (low certainty).
1 finding from 1 review
Pain intensity (0‐10cm visual analogue scale) · Women being investigated for infertility
1 finding from 1 review
All‐cause mortality(7‐day) · people with intermediate‐risk (submassive) APE
1 finding from 1 review
All‐cause mortality (90‐day) · people with intermediate‐risk (submassive) APE
It is very uncertain whether ultrasound‐assisted catheter‐directed thrombolysis plus standard… changes all‐cause mortality (90‐day) compared with standard intravenous heparinisation (very low certainty).
1 finding from 1 review
Treatment‐associated major haemorrhage ( · people with intermediate‐risk (submassive) APE
1 finding from 1 review
Treatment‐associated minor haemorrhage ( · people with intermediate‐risk (submassive) APE
It is very uncertain whether ultrasound‐assisted catheter‐directed thrombolysis plus standard… changes treatment‐associated minor haemorrhage ( compared with standard intravenous heparinisation (very low certainty).
1 finding from 1 review
Recurrent APE requiring retreatment or change to a different APE treatment ( · people with intermediate‐risk (submassive) APE
1 finding from 1 review
Length of hospital stay · people with intermediate‐risk (submassive) APE
1 finding from 1 review
Quality of life  · people with intermediate‐risk (submassive) APE
1 finding from 1 review
Change in frequency of vaso‐occlusive painful crises (as measured by pain diary days with significant pain) · people with sickle cell disease
1 finding from 1 review
HRQoL score (Child‐reported PedsQL generic scale) at 1 week · people with sickle cell disease
1 finding from 1 review
HRQoL score (Child‐reported PedsQL multidimensional fatigue scale) at 1 week · people with sickle cell disease
1 finding from 1 review